Home / Market News / $TDOC
fiscal.ai Corporate Catalyst Impact 55/100 ● positive

BofA Securities Adjusts Teladoc Health Price Target

Oct 30, 2026, 1:08 PM UTC · Primary ticker $TDOC

BofA Securities increased its price target for Teladoc Health shares to $11.50 from $10.50 following the company's Q3 2026 earnings report. This upward revision suggests a slightly more optimistic outlook from the analyst firm, potentially offering a modest positive sentiment for Teladoc's stock.

BofA Securities adjusted its price target for Teladoc Health, raising it by $1.00 to $11.50. This action directly follows Teladoc's third-quarter 2026 financial results, indicating that the analyst firm has re-evaluated its valuation model based on the latest performance data. For traders, this represents a moderately positive signal, as an increased price target from a major investment bank can influence investor sentiment and potentially lead to short-term buying interest. While not a dramatic shift, it suggests that BofA sees some upside potential from current levels. The long-term implications depend on whether other analysts follow suit and if Teladoc's future performance continues to justify such valuations. A key opportunity for traders is to monitor if this upgrade triggers a positive momentum shift, while a risk is that the market may have already priced in the Q3 results, limiting further upside from this specific analyst action.

$TDOC positive Analyst price target increase
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.